Viewing StudyNCT05813912



Ignite Creation Date: 2024-05-06 @ 6:53 PM
Last Modification Date: 2024-10-26 @ 2:56 PM
Study NCT ID: NCT05813912
Status: RECRUITING
Last Update Posted: 2024-05-07
First Post: 2023-04-03

Brief Title: A Research Study to See How a New Weekly Insulin Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes
Sponsor: Novo Nordisk AS
Organization: Novo Nordisk AS

Organization Data

Organization: Novo Nordisk AS
Class: INDUSTRY
Study ID: NN1436-4910
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novo Nordisk AS
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators